NCT07536061: A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease
- State
- Under way
- Phase
- Phase 1
- People
- 32 planned
- Started
- 12 May 2026
- Primary completion
- 30 Nov 2027
- Arms
- Cohort 1: SRP-1005 Dose 1, Cohort 2: SRP-1005 Dose 2, Cohort 3: SRP-1005 Dose 3, Cohort 4: SRP-1005 Dose 4
- Results
- None posted
- 17 Apr 2026: Trial registered
- 12 May 2026: Trial started